Medigen Vaccine Biologics Corporation (6547.TWO)

TWD 34.1

(-1.45%)

Annual Balance Sheets

(In TWD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 6.09 Billion 7.34 Billion 5.29 Billion 3.49 Billion 2.27 Billion 2.18 Billion
Total Current Assets 4.4 Billion 5.46 Billion 3.72 Billion 2 Billion 518.92 Million 772.42 Million
Cash And Short Term Investments 3.75 Billion 4.23 Billion 2.23 Billion 1.73 Billion 463.85 Million 719.59 Million
Cash and Cash Equivalents 1.35 Billion 1.2 Billion 1.37 Billion 1.67 Billion 410.62 Million 217.07 Million
Short Term Investments 2.4 Billion 3.03 Billion 853.09 Million 53.17 Million 53.23 Million 502.51 Million
Net Receivables 198.84 Million 566.55 Million 719.89 Million 148.01 Million -53.23 Million -2.71 Million
Inventory 383.63 Million 544.78 Million 563.49 Million 77.43 Million 8.39 Million 10.17 Million
Other Current Assets 61.62 Million 113.89 Million 205.07 Million 51.63 Million 46.68 Million 42.65 Million
Total Non-Current Assets 1.69 Billion 1.88 Billion 1.57 Billion 1.48 Billion 1.75 Billion 1.41 Billion
Net PPE 1.38 Billion 1.46 Billion 1.41 Billion 1.34 Billion 1.66 Billion 1.32 Billion
Good Will And Intangible Assets 38.29 Million 45.36 Million 52.97 Million 60.01 Million 61.8 Million 69.69 Million
Good Will - - - - - -
Intangible Assets 38.29 Million 45.36 Million 52.97 Million 60.01 Million 61.8 Million 69.69 Million
Long-Term Investments 246.13 Million -2.76 Billion -799.09 Million 7.62 Million 7.23 Million -
Tax Assets - 2.76 Billion 853.09 Million -7.62 Million -7.23 Million -
Other Non Current Assets 22.36 Million 370.38 Million 57.25 Million 77.7 Million 33.27 Million 18.97 Million
Other Assets - - - - - -
Total Liabilities 2.24 Billion 2.31 Billion 622.95 Million 349.4 Million 910.28 Million 571.09 Million
Total Current Liabilities 1.99 Billion 355.23 Million 439.08 Million 160.97 Million 227.82 Million 137.54 Million
Account Payables 25.88 Million 108.52 Million 86.8 Million 21.17 Million 1.89 Million 4.3 Million
Tax Payables - - - - - -
Short Term Debt 1.72 Billion 12.35 Million 3.71 Million 2.52 Million 147.85 Million 90.34 Million
Deferred Revenue - - 346.68 Million 136.75 Million - 42.41 Million
Other Current Liabilities 245.72 Million 234.35 Million 1.88 Million 513 Thousand 78.07 Million 474 Thousand
Total Non Current Liabilities 254.35 Million 1.96 Billion 183.86 Million 188.42 Million 682.45 Million 433.55 Million
Long-Term Debt 254.35 Million 1.94 Billion 183.86 Million 185.85 Million 682.45 Million 433.55 Million
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities - 19.25 Million - 2.57 Million - -
Other Liabilities - - - - - -
Total Equity 3.84 Billion 5.02 Billion 4.67 Billion 3.14 Billion 1.36 Billion 1.61 Billion
Stock Holders Equity 3.84 Billion 5.02 Billion 4.67 Billion 3.14 Billion 1.36 Billion 1.61 Billion
Common Stock 3.28 Billion 3.28 Billion 2.13 Billion 2.11 Billion 1.69 Billion 1.55 Billion
Retained Earnings -1.15 Billion -1.27 Billion 1.41 Billion -1.29 Billion -617.71 Million -476.34 Million
Accumulated other comprehensive income 421.76 Million 469.04 Million 94.87 Million 44.24 Million 184.12 Million 28.77 Million
Common Stock Equity 3.84 Billion 5.02 Billion 4.67 Billion 3.14 Billion 1.36 Billion 1.61 Billion
Capital Lease Obligation 254.35 Million 278.13 Million 185.85 Million 187.78 Million 334.72 Million -
Total Investments 2.65 Billion 263.55 Million 54 Million 53.17 Million 53.23 Million 502.51 Million
Total Debt 1.97 Billion 1.95 Billion 187.58 Million 188.37 Million 830.31 Million 523.89 Million
Net Debt 621.53 Million 752.3 Million -1.19 Billion -1.49 Billion 419.69 Million 306.81 Million

Balance Sheet Charts